Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassem Sadek

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Drug Design, Development and Therapy|June 13, 2014
Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H₃ receptor antagonist ST-1283Amine Bahi, Johannes Stephan Schwed, Miriam Walter, et al.
Neuropsychiatric Disease and Treatment|March 14, 2019
Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in ratsAlaa Alachkar, Nadia Khan, Dorota Łażewska, et al.
Drug Design, Development and Therapy|October 4, 2014
Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligandsBassem Sadek, Annemarie Schreeb, Johannes Stephan Schwed, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated ComorbiditiesAli K Saad, Amal Akour, Abdulla Mahboob, et al.
Frontiers in Pharmacology|June 20, 2022
Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle DisorderMera Alhusaini, Nermin Eissa, Ali K Saad, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Canagliflozin Ameliorates Oxidative Stress and Autistic-like Features in Valproic-Acid-Induced Autism in Rats: Comparison with Aripiprazole ActionMohammed Moutaz Nakhal, Petrilla Jayaprakash, Salahdein Aburuz, et al.
Biomolecules|May 28, 2022
The Novel Pimavanserin Derivative ST-2300 with Histamine H<sub>3</sub> Receptor Affinity Shows Reduced 5-HT<sub>2A</sub> Binding, but Maintains Antidepressant- and Anxiolytic-like Properties in MiceKarthikkumar Venkatachalam, Sicheng Zhong, Mariam Dubiel, et al.
Molecules (Basel, Switzerland)|January 11, 2022
In Vitro and In Vivo Antidiabetic Potential of Monoterpenoids: An UpdateLina T Al Kury, Aya Abdoh, Kamel Ikbariah, et al.
Physiology & Behavior|July 15, 2015
The novel non-imidazole histamine H3 receptor antagonist DL77 reduces voluntary alcohol intake and ethanol-induced conditioned place preference in miceAmine Bahi, Bassem Sadek, Syed M Nurulain, et al.
Oxidative Medicine and Cellular Longevity|October 25, 2016
Plant-Derived Agents for Counteracting Cisplatin-Induced NephrotoxicityShreesh Ojha, Balaji Venkataraman, Amani Kurdi, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Drug Design, Development and Therapy|June 13, 2014
Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H₃ receptor antagonist ST-1283Amine Bahi, Johannes Stephan Schwed, Miriam Walter, et al.
Neuropsychiatric Disease and Treatment|March 14, 2019
Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in ratsAlaa Alachkar, Nadia Khan, Dorota Łażewska, et al.
Drug Design, Development and Therapy|October 4, 2014
Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligandsBassem Sadek, Annemarie Schreeb, Johannes Stephan Schwed, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated ComorbiditiesAli K Saad, Amal Akour, Abdulla Mahboob, et al.
Frontiers in Pharmacology|June 20, 2022
Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle DisorderMera Alhusaini, Nermin Eissa, Ali K Saad, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Canagliflozin Ameliorates Oxidative Stress and Autistic-like Features in Valproic-Acid-Induced Autism in Rats: Comparison with Aripiprazole ActionMohammed Moutaz Nakhal, Petrilla Jayaprakash, Salahdein Aburuz, et al.
Biomolecules|May 28, 2022
The Novel Pimavanserin Derivative ST-2300 with Histamine H<sub>3</sub> Receptor Affinity Shows Reduced 5-HT<sub>2A</sub> Binding, but Maintains Antidepressant- and Anxiolytic-like Properties in MiceKarthikkumar Venkatachalam, Sicheng Zhong, Mariam Dubiel, et al.
Molecules (Basel, Switzerland)|January 11, 2022
In Vitro and In Vivo Antidiabetic Potential of Monoterpenoids: An UpdateLina T Al Kury, Aya Abdoh, Kamel Ikbariah, et al.
Physiology & Behavior|July 15, 2015
The novel non-imidazole histamine H3 receptor antagonist DL77 reduces voluntary alcohol intake and ethanol-induced conditioned place preference in miceAmine Bahi, Bassem Sadek, Syed M Nurulain, et al.
Oxidative Medicine and Cellular Longevity|October 25, 2016
Plant-Derived Agents for Counteracting Cisplatin-Induced NephrotoxicityShreesh Ojha, Balaji Venkataraman, Amani Kurdi, et al.
Pageof 10